Home › Interdigitating Dendritic Cell Sarcoma › New York › New York City
Interdigitating Dendritic Cell Sarcoma clinical trials in New York City, NY
3 studies for Interdigitating Dendritic Cell Sarcoma are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
RecruitingPhase 1
- Memorial Sloan Kettering Cancer Center - Bergen, New York
A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
RecruitingPhase 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
Recruiting
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
- NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only), New York
Other studies in New York City
- Breast Cancer134 studies
- Non-Small Cell Lung Cancer120 studies
- Cancer (all types)110 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer77 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Pancreatic Cancer60 studies
- Multiple Myeloma60 studies
- Endometrial Cancer52 studies
- Heart Failure51 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.